Your browser doesn't support javascript.
loading
Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma.
Salama, April K S; Palta, Manisha; Rushing, Christel N; Selim, M Angelica; Linney, Kristen N; Czito, Brian G; Yoo, David S; Hanks, Brent A; Beasley, Georgia M; Mosca, Paul J; Dumbauld, Chelsae; Steadman, Katelyn N; Yi, John S; Weinhold, Kent J; Tyler, Douglas S; Lee, Walter T; Brizel, David M.
Afiliação
  • Salama AKS; Department of Medicine, Division of Medical Oncology, Duke University, Durham, North Carolina. april.salama@duke.edu.
  • Palta M; Department of Radiation Oncology, Duke University, Durham, North Carolina.
  • Rushing CN; Biostatistics, Duke Cancer Institute, Durham, North Carolina.
  • Selim MA; Department of Pathology, Duke University, Durham, North Carolina.
  • Linney KN; Duke Clinical Research Institute, Durham, North Carolina.
  • Czito BG; Department of Radiation Oncology, Duke University, Durham, North Carolina.
  • Yoo DS; Department of Radiation Oncology, Duke University, Durham, North Carolina.
  • Hanks BA; Department of Medicine, Division of Medical Oncology, Duke University, Durham, North Carolina.
  • Beasley GM; Department of Pharmacology and Cancer Biology, Durham, North Carolina.
  • Mosca PJ; Department of Surgery, Duke University, Durham, North Carolina.
  • Dumbauld C; Department of Surgery, Duke University, Durham, North Carolina.
  • Steadman KN; Department of Immunology, Mayo Clinic Scottsdale, Scottsdale, Arizona.
  • Yi JS; Department of Surgery, Duke University, Durham, North Carolina.
  • Weinhold KJ; Department of Surgery, Duke University, Durham, North Carolina.
  • Tyler DS; Department of Surgery, Duke University, Durham, North Carolina.
  • Lee WT; Department of Surgery, The University of Texas Medical Branch at Galveston, Galveston, Texas.
  • Brizel DM; Department of Head and Neck Surgery & Communication Sciences, Duke University, Durham, North Carolina.
Clin Cancer Res ; 27(5): 1287-1295, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33172894
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Quimiorradioterapia Adjuvante / Ipilimumab / Melanoma / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Quimiorradioterapia Adjuvante / Ipilimumab / Melanoma / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article